Features

Features

Duchenne muscular dystrophy: Five trials to watch

The beginning to the year has been eventful in the Duchenne muscular dystrophy (DMD) space, with several trial readouts announced…

Joshua Silverwood

Features

Rising Sirturo resistance highlights urgent need for new TB therapies

Features

Funding drought: how can biotech and biopharma keep trials running?

Features

Amid deglobalising trade, experts seek AI safeguards for clinical trial supply

Features

Are European biopharma manufacturers ‘nearshoring’?

Features

Inborn errors of metabolism elicit unique challenges for therapy development

Features

NeOnc: bypassing the blood-brain barrier in brain cancer

Features

OCT West Coast 2025: Recruitment and regulation remain pain points

Features

Podcast: How Trump’s tariffs will impact clinical trials

Features

Trump’s tariffs will trickle down the clinical trial chain

Features

OCT Medical Devices 2025: AI’s value appreciable, yet human touch remains key

Features

The AI advantage in discovering new medicines

Excellence Awards

Clinical Trials Arena Excellence Awards 2024 – Winners Announced!

Features

The biggest challenges clinical trials will face in 2025

Features

Most significant clinical trials of 2024

Features

CTO Europe 2024: keep the burden of trials away from patients, say experts

Joshua Silverwood

Features

ADCs breach barriers to become mainstream cancer treatment

Natasha Spencer-Jolliffe

Features

WHO trial guidance goes beyond race and gender when tackling diversity

Features

Experts call for a shift from reactive to proactive clinical trial supply frameworks

Features

US reproductive laws could limit women’s participation in clinical trials

Phalguni Deswal

Features

Does Southeast Asia have a growing role in vaccine development?

Features

Prostate cancer: Three drug trials to watch

Features

How decentralisation can fill the gaps in Alzheimer’s research

Jenna Philpott and Irena Maragkou

Features

Preparing for DSCSA transition with tech-led compliance

Natasha Spencer-Jolliffe

Features

Adapting diabetes clinical trials to embrace underrepresented communities

Features

Mapping out strategies to overcome challenges in clinical research

Features

BIOSECURE Act: Companies turn to US manufacturers

Features

Obesity trial surge puts the focus back on decentralisation

Jenna Philpott and Irena Maragkou

Features

Cassava Sciences: Phase III trials storm ahead amid controversy

Features

Ushering in a new era of fit-for-purpose clinical endpoints for Rett syndrome

Features

Pipeline Moves: Pfizer scores in Phase II cancer cachexia trial

Clinical Trials Arena Team

Features

Mpox: Three ongoing vaccine trials to watch

Features

Pipeline Moves: Novo Nordisk’s liraglutide scores in Phase III paediatric trial

Clinical Trials Arena Team

Features

Alzheimer’s heterogeneity necessitates diverse enrollment in clinical trials

Features

How the Covid-19 pandemic will help researchers with the mpox emergency

Features

Pipeline Moves: Investigator-led oncology cell therapy trial terminated

Clinical Trials Arena Team

Features

DMD clinical studies evolve with emphasis on building designs around relevant endpoints

Features

What is mpox and how big of a threat is it?

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close